Pediatrix Medical Group, Inc. (MD) Stock Analysis
Healthcare · Medical Care Facilities · NYSE
Pediatrix Medical Group, Inc. (MD) posted $1.91B in revenue for fiscal 2025 (down 4.9% year over year), at a 8.6% net margin, and has compounded revenue about 2.0%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc. has grown revenue from $3.18B to $1.91B over the last 10 fiscal years, compounding about 2% a year. The most recent year was down 4.9%, so growth has cooled from its longer-run pace.
Net margin sits at 8.6%, up 13.5 points year over year.
Synthesised from Pediatrix Medical Group, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
Pediatrix Medical Group, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18B | $3.25B | $1.72B | $1.78B | $1.73B | $1.91B | $1.97B | $1.99B | $2.01B | $1.91B |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Net income | $324.91M | $320.37M | $268.63M | $-1.50B | $-796.49M | $130.96M | $66.33M | $-60.41M | $-99.07M | $165.39M |
| Net margin | 10.2% | 9.8% | 15.6% | -84.2% | -45.9% | 6.9% | 3.4% | -3.0% | -4.9% | 8.6% |
Source: Pediatrix Medical Group, Inc. SEC filings (10-K). 18 years of history available in the interactive view.
Pediatrix Medical Group, Inc.: no obvious red flags in the filings
Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →
Explore 18 years of Pediatrix Medical Group, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freePediatrix Medical Group, Inc. financial history by metric
Compare Pediatrix Medical Group, Inc. with peers
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Pediatrix Medical Group, Inc. — frequently asked questions
What is Pediatrix Medical Group, Inc.'s revenue?
Pediatrix Medical Group, Inc. (MD) reported revenue of $1.91B for fiscal year 2025, down 4.9% from the prior year, according to its SEC filings.
Is Pediatrix Medical Group, Inc. profitable?
Yes. MD earned net income of $165.39M in fiscal 2025, a net margin of 8.6%.
What is MD's P/E ratio?
Pediatrix Medical Group, Inc. trades at a price-to-earnings ratio of about 11.5 based on the latest data in our nightly-refreshed cache.
How fast is Pediatrix Medical Group, Inc. growing?
MD's revenue grew at roughly 2.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Pediatrix Medical Group, Inc. have?
As of fiscal year 2025, MD carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Pediatrix Medical Group, Inc.'s market cap?
Pediatrix Medical Group, Inc. (MD) has a market capitalization of about $1.94B, based on the latest data in our nightly-refreshed cache.
When does Pediatrix Medical Group, Inc.'s fiscal year end?
MD's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Pediatrix Medical Group, Inc.'s official SEC filings (10-K and 10-Q), covering 18 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.